177 related articles for article (PubMed ID: 21624564)
1. The next generation of cardiac positron emission tomography imaging agents: discovery of flurpiridaz F-18 for detection of coronary disease.
Yu M; Nekolla SG; Schwaiger M; Robinson SP
Semin Nucl Med; 2011 Jul; 41(4):305-13. PubMed ID: 21624564
[TBL] [Abstract][Full Text] [Related]
2. Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography.
Berman DS; Maddahi J; Tamarappoo BK; Czernin J; Taillefer R; Udelson JE; Gibson CM; Devine M; Lazewatsky J; Bhat G; Washburn D
J Am Coll Cardiol; 2013 Jan; 61(4):469-477. PubMed ID: 23265345
[TBL] [Abstract][Full Text] [Related]
3. Flurpiridaz F-18 PET Myocardial Perfusion Imaging in Patients With Suspected Coronary Artery Disease.
Maddahi J; Agostini D; Bateman TM; Bax JJ; Beanlands RSB; Berman DS; Dorbala S; Garcia EV; Feldman J; Heller GV; Knuuti JM; Martinez-Clark P; Pelletier-Galarneau M; Shepple B; Tamaki N; Tranquart F; Udelson JE
J Am Coll Cardiol; 2023 Oct; 82(16):1598-1610. PubMed ID: 37821170
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and preliminary evaluation of 18F-labeled pyridaben analogues for myocardial perfusion imaging with PET.
Mou T; Zhao Z; Fang W; Peng C; Guo F; Liu B; Ma Y; Zhang X
J Nucl Med; 2012 Mar; 53(3):472-9. PubMed ID: 22302832
[TBL] [Abstract][Full Text] [Related]
5. Phase-III Clinical Trial of Fluorine-18 Flurpiridaz Positron Emission Tomography for Evaluation of Coronary Artery Disease.
Maddahi J; Lazewatsky J; Udelson JE; Berman DS; Beanlands RSB; Heller GV; Bateman TM; Knuuti J; Orlandi C
J Am Coll Cardiol; 2020 Jul; 76(4):391-401. PubMed ID: 32703509
[TBL] [Abstract][Full Text] [Related]
6. Moving into the next era of PET myocardial perfusion imaging: introduction of novel
Werner RA; Chen X; Rowe SP; Lapa C; Javadi MS; Higuchi T
Int J Cardiovasc Imaging; 2019 Mar; 35(3):569-577. PubMed ID: 30334228
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and bioevaluation of 4-chloro-2-tert-butyl-5-[2-[[1-[2-[(18) F]fluroethyl]-1H-1,2,3-triazol-4-yl]methyl]phenylmethoxy]-3(2H)-pyridazinone as potential myocardial perfusion imaging agent with PET.
Mou T; Zhao Z; You L; Wang Q; Fang W; Lu J; Peng C; Zhang X
J Labelled Comp Radiopharm; 2015 Jun; 58(8):349-54. PubMed ID: 26094722
[TBL] [Abstract][Full Text] [Related]
8. Assessment of 18F-labeled mitochondrial complex I inhibitors as PET myocardial perfusion imaging agents in rats, rabbits, and primates.
Yu M; Guaraldi M; Kagan M; Mistry M; McDonald J; Bozek J; Yalamanchili P; Hayes M; Azure M; Purohit A; Radeke H; Casebier DS; Robinson SP
Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):63-72. PubMed ID: 18716773
[TBL] [Abstract][Full Text] [Related]
9. Assessing myocardial perfusion in suspected coronary artery disease: rationale and design of the second phase 3, open-label multi-center study of flurpiridaz (F-18) injection for positron emission tomography (PET) imaging.
Bourque JM; Hanson CA; Agostini D; Bateman TM; Bax JJ; Beanlands RSB; Berman DS; Garcia EV; Heller GV; Knuuti J; Tamaki N; Udelson JE; Maddahi J
J Nucl Cardiol; 2021 Jun; 28(3):1105-1116. PubMed ID: 33521873
[TBL] [Abstract][Full Text] [Related]
10. Rest/stress myocardial perfusion imaging by positron emission tomography with
Bengs S; Warnock GI; Portmann A; Mikail N; Rossi A; Ahmed H; Etter D; Treyer V; Gisler L; Pfister SK; Jie CVML; Meisel A; Keller C; Liang SH; Schibli R; Mu L; Buechel RR; Kaufmann PA; Ametamey SM; Gebhard C; Haider A
J Nucl Cardiol; 2023 Feb; 30(1):62-73. PubMed ID: 35484467
[TBL] [Abstract][Full Text] [Related]
11. Simplified quantification of myocardial flow reserve with flurpiridaz F 18: validation with microspheres in a pig model.
Sherif HM; Nekolla SG; Saraste A; Reder S; Yu M; Robinson S; Schwaiger M
J Nucl Med; 2011 Apr; 52(4):617-24. PubMed ID: 21441533
[TBL] [Abstract][Full Text] [Related]
12. Stress thallium-201/rest technetium-99m sequential dual isotope high-speed myocardial perfusion imaging.
Berman DS; Kang X; Tamarappoo B; Wolak A; Hayes SW; Nakazato R; Thomson LE; Kite F; Cohen I; Slomka PJ; Einstein AJ; Friedman JD
JACC Cardiovasc Imaging; 2009 Mar; 2(3):273-82. PubMed ID: 19356571
[TBL] [Abstract][Full Text] [Related]
13. [
Ahmed H; Haider A; Gisler L; Schibli R; Gebhard C; Ametamey SM
ChemMedChem; 2020 Jun; 15(12):1040-1043. PubMed ID: 32324949
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of 123I-CMICE-013: a potential SPECT myocardial perfusion imaging agent.
Wei L; Bensimon C; Lockwood J; Yan X; Fernando P; Wells RG; Duan Y; Chen YX; Redshaw JR; Covitz PA; Ruddy TD
Bioorg Med Chem; 2013 Jun; 21(11):2903-11. PubMed ID: 23608108
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Performance of PET Versus SPECT Myocardial Perfusion Imaging in Patients with Smaller Left Ventricles: A Substudy of the
Packard RRS; Lazewatsky JL; Orlandi C; Maddahi J
J Nucl Med; 2021 Jun; 62(6):849-854. PubMed ID: 33246979
[TBL] [Abstract][Full Text] [Related]
16. Optimization of imaging protocols for myocardial blood flow (MBF) quantification with
Wiyaporn K; Tocharoenchai C; Pusuwan P; Higuchi T; Fung GSK; Feng T; Park MJ; Tsui BMW
Phys Med; 2017 Oct; 42():127-134. PubMed ID: 29173905
[TBL] [Abstract][Full Text] [Related]
17. The Potential of F-18 Flurpiridaz PET/CT Myocardial Perfusion Imaging for Precision Imaging.
Patel KK; Singh A; Bateman TM
Curr Cardiol Rep; 2022 Aug; 24(8):987-994. PubMed ID: 35616882
[TBL] [Abstract][Full Text] [Related]
18. Improvement in PET myocardial perfusion image quality and quantification with flurpiridaz F 18.
Berman DS; Germano G; Slomka PJ
J Nucl Cardiol; 2012 Feb; 19 Suppl 1():S38-45. PubMed ID: 22259005
[TBL] [Abstract][Full Text] [Related]
19. Preliminary and Comparative Experiment Study Between
Wang J; Mpharm SL; Liu TW; Zhang JM; Chen Y; Li JM; Xu WG
Mol Imaging; 2020; 19():1536012120947506. PubMed ID: 32758064
[TBL] [Abstract][Full Text] [Related]
20. Automatic 3D registration of dynamic stress and rest (82)Rb and flurpiridaz F 18 myocardial perfusion PET data for patient motion detection and correction.
Woo J; Tamarappoo B; Dey D; Nakazato R; Le Meunier L; Ramesh A; Lazewatsky J; Germano G; Berman DS; Slomka PJ
Med Phys; 2011 Nov; 38(11):6313-26. PubMed ID: 22047396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
